NPC @ 13th Annual Personalized Medicine Conference

  • November 14, 9:45am - November 15 5:00pm, 2018
NPC logo

Join NPC at the 13th Annual Personalized Medicine Conference, hosted by the Personalized Medicine Coalition, on Nov. 14-16 in Boston, Massachusetts. NPC Executive Vice President and Chief Science Officer Robert W. Dubois, MD, PhD, will participate in a panel discussion on “Precision Valuation: A Discussion of How Value Assessment Frameworks Can Account for Personalized Medicine” (Nov. 15 at 3:15 p.m.). Additionally, Joshua Ofman, MD, MSHS, Senior Vice President of Global Value, Access & Policy, Amgen, and 2017 Chairman of NPC’s Board of Directors, will speak on “A Model for Risk-Sharing Agreements Between Payers and the Pharmaceutical Industry” (Nov. 15 at 9:45 a.m.).

Sessions

A Model for Risk-Sharing Agreements Between Payers and the Pharmaceutical Industry

Wednesday, Nov. 15, 9:45 a.m.

Joshua Ofman, MD, MSHS, Senior Vice President of Global Value, Access & Policy, Amgen, and 2017 Chairman of NPC’s Board of Directors, will be a panelist in this fireside chat series discussing the logic and implications of risk-sharing agreements.

Moderator: Meg Tirrell, M.S.J., Reporter, CNBC

Panelists:

  • Joshua Ofman, M.D., M.S.H.S., Senior Vice President, Global Value, Access & Policy, Amgen Inc.
  • Michael Sherman, M.D., M.B.A., M.S., Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care

Precision Valuation: A Discussion of How Value Assessment Frameworks Can Account for Personalized Medicine

Wednesday, Nov. 15, 3:45 p.m.

NPC Executive Vice President and Chief Science Officer Robert W. Dubois, MD, PhD, will participate in a panel discussion examining how value frameworks can impact individualized care, and how frameworks can/should address personalized medicine when evaluating treatments.

Moderator: Jennifer Snow, M.P.H, Director, Health Policy, Xcenda

Panelists:

  • Robert Dubois, M.D., Ph.D., Chief Science Officer, Executive Vice President, National Pharmaceutical Council
  • Dane J. Dickson, M.D., CEO, Cure-One (formerly MED-C); Director, Precision Medicine Policy and Registries, Knight Cancer Center at OHSU
  • Steven Pearson, M.D., M.Sc., Founder and President, Institute for Clinical and Economic Review (ICER)
  • Andrea Ferris, M.B.A., President, Chairman of the Board, LUNGevity Foundation